New Data Strengthen Case For RemeGen’s Telitacicept In gMG

‘Highest’ MG-ADL Response Rate

 
• By Dexter Jie Yan
  
Concept of Myasthenia Gravis written on sticky notes isolated on Wooden Table.
RemeGen has shown telitacicept's potenial as a an alternative to FcRn Inhibitors In gMG. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from Rare Diseases